Pig-to-human lung xenotransplantation right into a brain-dead recipient

This web page was created programmatically, to learn the article in its authentic location you may go to the hyperlink bellow:
https://pubmed.ncbi.nlm.nih.gov/40855190/
and if you wish to take away this text from our web site please contact us




doi: 10.1038/s41591-025-03861-x.


Online forward of print.

Jianxing He # 
1
 
2
Jiang Shi # 
3
 
4
Chao Yang # 
3
 
4
Guilin Peng # 
3
 
4
Chunrong Ju # 
4
Yi Zhao 
3
Hui Liu 
5
Ping He 
6
Xiaoqing Liu 
7
Zuopeng Zhang 
8
Chuanbao Chen 
4
Dengke Pan 
9
Zifeng Yang 
10
Wenda Guang 
10
Hongtao Li 
11
Zhonghua Chen 
12
 
13
Menyang Liu 
4
Hengrui Liang 
3
Weiqing Huang 
8
Kyeongman Jeon 
14
Toyofumi F Chen-Yoshikawa 
15
A Justin Rucker 
16
Amos Lal 
17
Nanshan Zhong 
18
 
19
 
20
Kang Zhang 
21
 
22
Xiaoyou Liu 
23
Xin Xu 
24
 
25

Affiliations

Item in Clipboard

Jianxing He et al.


Nat Med.


.

Abstract

Genetically engineered pig lungs haven’t beforehand been transplanted into people, leaving key questions unanswered concerning the human immune response within the context of a xenotransplanted lung and the opportunity of hyperacute rejection. Here, we report a case of pig-to-human lung xenotransplantation, by which a lung from a six-gene-edited pig was transplanted right into a 39-year-old brain-dead male human recipient following a mind hemorrhage. The lung xenograft maintained viability and performance over the course of the 216 hours of the monitoring interval, with out indicators of hyperacute rejection or an infection. Severe edema resembling main graft dysfunction was noticed at 24 hours after transplantation, probably attributable to ischemia-reperfusion damage. Antibody-mediated rejection appeared to contribute to xenograft injury on postoperative days 3 and 6, with partial restoration by day 9. Immunosuppression included rabbit anti-thymocyte globulin, basiliximab, rituximab, eculizumab, tofacitinib, tacrolimus, mycophenolate mofetil and tapering steroids, with changes made throughout the postoperative interval primarily based on assessments of immune standing. Although this examine demonstrates the feasibility of pig-to-human lung xenotransplantation, substantial challenges regarding organ rejection and an infection stay, and additional preclinical research are essential earlier than medical translation of this process.

PubMed Disclaimer

Conflict of curiosity assertion

Competing pursuits: D.P. is a co-founder of Chengdu Clonorgan Biotechnology Co. Ltd, Chengdu, China. The different authors declare competing pursuits.

Similar articles

  • Genetically Modified Porcine Kidneys Have Sufficient Tissue Integrity for Use in Pig-to-Human Xenotransplantation.

    Anderson DJ, Jones-Carr M, Perry J, Kumar V, Porrett PM, Locke JE.

    Anderson DJ, et al.
    Ann Surg. 2024 Sep 1;280(3):374-382. doi: 10.1097/SLA.0000000000006380. Epub 2024 Jun 6.
    Ann Surg. 2024.

    PMID: 38842179

  • Prescription of Controlled Substances: Benefits and Risks.

    Preuss CV, Kalava A, King KC.

    Preuss CV, et al.
    2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
    2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.

    PMID: 30726003
    Free Books & Documents.

  • Belatacept for kidney transplant recipients.

    Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.

    Masson P, et al.
    Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2.
    Cochrane Database Syst Rev. 2014.

    PMID: 25416857
    Free PMC article.

  • A scientific overview and financial mannequin of the medical and cost-effectiveness of immunosuppressive remedy for renal transplantation in youngsters.

    Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, Raftery J, Taylor RS.

    Yao G, et al.
    Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. doi: 10.3310/hta10490.
    Health Technol Assess. 2006.

    PMID: 17134597

  • Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a scientific overview and modelling examine.

    Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

    Woodroffe R, et al.
    Health Technol Assess. 2005 May;9(21):1-179, iii-iv. doi: 10.3310/hta9210.
    Health Technol Assess. 2005.

    PMID: 15899149

References

    1. Chisholm-Burns, M., Kelly, B. S. & Spivey, C. A. Xenotransplantation might both be a buddy or foe of healthcare fairness. Commun. Med. (Lond.) 4, 85 (2024).

      PubMed



      PMC

    1. Mohiuddin, M. M. et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report. Lancet 402, 397–410 (2023).

      PubMed



      PMC

    1. Mallapaty, S. & Kozlov, M. First pig kidney transplant in an individual: what it means for the long run. Nature 628, 13–14 (2024).

      PubMed

    1. Wang, Y. et al. Pig-to-human kidney xenotransplants utilizing genetically modified minipigs. Cell Rep. Med. 5, 101744 (2024).

      PubMed



      PMC

    1. Burdorf, L. et al. Pig-to-baboon lung xenotransplantation: prolonged survival with focused genetic modifications and pharmacologic remedies. Am. J. Transplant. 22, 28–45 (2022).

      PubMed